• ABOUT US
  • SCIENCE
  • FACILITY
  • INVESTORS
    • Media
    • Notice
    • Public Disclosures
    • Stock Information
    • Financials
  • ESG
    • ESG Management
    • Archive
  • CONTACT
  • ABOUT US
  • SCIENCE
  • FACILITY
  • INVESTORS
    • Media
    • Notice
    • Public Disclosures
    • Stock Information
    • Financials
  • ESG
    • ESG Management
    • Archive
  • CONTACT

INVESTORS

[데일리팜] “국산 최초 CAR-T 치료제 개발, 킴리아에 도전장”

2024/08/05

[데일리팜] 국산 최초 CAR-T 치료제 개발, 킴리아에 도전장 (dailypharm.com)

Prev[헬로디디] 혈액암에 이어 고형암까지···모든 암 정복 꿈꾸는 큐로셀에 관심 집중
Next큐로셀 ‘안발셀’, 식약처로부터 신속처리 대상 첨단바이오의약품 지정… 심사 기간 단축해 신약 허가 가속화
Copyright 2023. Curocell Inc. All Rights Reserved.
Created by PRESSCAT
  • ABOUT US
  • SCIENCE
  • FACILITY
  • INVESTORS
    • Media
    • Notice
    • Public Disclosures
    • Stock Information
    • Financials
  • ESG
    • ESG Management
    • Archive
  • CONTACT
  • ABOUT US
  • SCIENCE
  • FACILITY
  • INVESTORS
    • Media
    • Notice
    • Public Disclosures
    • Stock Information
    • Financials
  • ESG
    • ESG Management
    • Archive
  • CONTACT
Copyright 2023. Curocell Inc. All Rights Reserved.